Fujitsu has announced the launch of a new cloud-based platform. In addition, the platform allows users to securely collect and leverage health-related data to promote digital transformation in the medical field.
Fujitsu will offer the new platform to medical institutions and pharmaceutical companies in Japan starting March 28, 2023.
How will the new platform of Fujitsu work?
The new platform enables the automatic conversion of medical data from medical institutions’ electronic medical records to conform with the next-generation standards framework HL7 FHIR.
Additionally, it secures the aggregation of health-related data. Based on their consent, patients can securely store personal health information such as vital data, step counts, and calorie consumption.
Further, the data converts into non-personally identifiable information on the platform. As a result, it supports medical institutions and pharmaceutical companies in performing data analysis. Moreover, it supports R&D activities to accelerate the development of individualized healthcare and the discovery of new drugs.
Also Read: https://thecitizenscoop.com/nvidia-unveiled-new-research-on-using-ai/
Fujitsu will use the platform as a launching point for further planning to develop a data portability service. Additionally, it will enable patients to view their medical data on their smartphones. Further, it will help as a service for medical institutions to conduct highly accurate analyses of shared medical data on the platform.
Conclusion
Moving forward, Fujitsu aims to leverage this platform to realize an AI and IoT-based preventive healthcare system and cooperate with various medical institutions and companies to realize a digital health ecosystem that creates new value for society.
